Autor: "Scheulen, M. E." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study.
Autorzy:: Strumberg D; Department of Hematology and Medical Oncology, University of Bochum, Marienhospital Herne, Hölkeskampring 40, D-44625 Herne, Germany. />Scheulen ME
Schultheis B
Richly H
Frost A
Büchert M
Christensen O
Jeffers M
Heinig R
Boix O
Mross K; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2012 May 22; Vol. 106 (11), pp. 1722-7. Date of Electronic Publication: 2012 May 08.
Typ publikacji:: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Agents/*administration & dosage
Colorectal Neoplasms/*drug therapy
Phenylurea Compounds/*administration & dosage
Pyridines/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/pharmacokinetics ; Colorectal Neoplasms/mortality ; Disease-Free Survival ; Dose-Response Relationship, Drug ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Phenylurea Compounds/adverse effects ; Phenylurea Compounds/pharmacokinetics ; Pyridines/adverse effects ; Pyridines/pharmacokinetics

Czasopismo naukowe

Skocz do pozycji: 2.

Tytuł:: Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours.
Autorzy:: Strumberg D; Department of Haematology and Medical Oncology, University of Bochum (Marien Hospital, Herne), Herne, Germany. />Schultheis B
Adamietz IA
Christensen O
Buechert M
Kraetzschmar J
Rajagopalan P
Ludwig M
Frost A
Steinbild S
Scheulen ME
Mross K; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2008 Nov 18; Vol. 99 (10), pp. 1579-85.
Typ publikacji:: Clinical Trial, Phase I; Journal Article; Multicenter Study
MeSH Terms:: Angiogenesis Inhibitors/*administration & dosage
Antineoplastic Agents/*administration & dosage
Neoplasms/*drug therapy
Pyridazines/*administration & dosage
Pyridines/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged

Czasopismo naukowe

Skocz do pozycji: 3.

Tytuł:: Oxaliplatin-DNA adduct formation in white blood cells of cancer patients.
Autorzy:: Pieck AC; Institute of Pharmacy, Department of Clinical Pharmacy, University of Bonn, Bonn, Germany.
Drescher A
Wiesmann KG
Messerschmidt J
Weber G
Strumberg D
Hilger RA
Scheulen ME
Jaehde U; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2008 Jun 17; Vol. 98 (12), pp. 1959-65. Date of Electronic Publication: 2008 May 27.
Typ publikacji:: Clinical Trial, Phase I; Journal Article
MeSH Terms:: Antineoplastic Agents/*blood
DNA Adducts/*blood
Leukocytes/*metabolism
Neoplasms/*blood
Organoplatinum Compounds/*blood
Antineoplastic Agents/adverse effects ; Antineoplastic Agents/pharmacology ; Humans ; Organoplatinum Compounds/adverse effects ; Organoplatinum Compounds/pharmacology ; Oxaliplatin

Czasopismo naukowe

Skocz do pozycji: 4.

Tytuł:: A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network
Autorzy:: Mross, K
Dittrich, C
Aulitzky, W E
Strumberg, D
Schutte, J
Schmid, R M
Hollerbach, S
Merger, M
Munzert, G
Fleischer, F
Scheulen, M E; Pokaż więcej
Temat:: CANCER patients
PANCREATIC cancer
POLO-like kinases
ENZYME inhibitors
CANCER chemotherapy
ANTINEOPLASTIC agents
RANDOMIZED controlled trials
CANCER invasiveness
CONFIDENCE intervals
Źródło:: British Journal of Cancer; 7/10/2012, Vol. 107 Issue 2, p280-286, 7p

Czasopismo naukowe

Informacja